Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors. [electronic resource]
- BMC cancer Sep 2013
- 401 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1471-2407
10.1186/1471-2407-13-401 doi
Adult Aged Aged, 80 and over Antineoplastic Agents--adverse effects Aromatase Inhibitors--adverse effects Arthralgia--etiology Breast Neoplasms--complications Female Humans Middle Aged Neoplasm Staging Prognosis Retrospective Studies Risk Factors Survivors